Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Interventional cardiologists call out ABIM for ‘unfair and unjustified’ certification policies

“This situation unacceptably exacerbates the interventional cardiology workforce shortage and threatens to directly impact the care of patients," SCAI wrote in a new statement. 

Thumbnail

Expanding Medicaid linked to better care for heart patients

New research, based on data from approximately 143 million patients, focused on prescriptions for heart failure, atrial fibrillation and other significant cardiac conditions. 

Hospital financial trouble

AHA urges hospital stakeholders to wake up and smell the financial trouble that’s been brewing

The American Hospital Association is sounding the alarm over evidently widespread acceptance of 0% operating margins—or even negative margins—as a sort of “new normal” for U.S. hospitals and health systems.  

TikTok doc loses medical license after livestreaming procedures on social media

At least 11 patients have come forward regarding severe complications stemming from treatments and procedures completed by "Dr. Roxy."

Thumbnail

Healthcare industry to be impacted by OSHA's new injury/illness reporting requirements

The new rule on reporting work-related injuries and illnesses is set to take effect on January 1, 2024.

Thumbnail

HHS launches federal investigation into Cedars-Sinai's treatment of Black mothers

The civil rights probe follows a wrongful death lawsuit filed by Charles Johnson IV after the untimely death of his wife, who had undergone a planned cesarean section in 2016.

the words "FDA recall" on a board

Medtronic recalls nearly 350,000 implantable heart devices after 22 injuries

The FDA has categorized this as a Class I recall, meaning the use of these devices could cause serious injuries or death.”

fda approves first daily oral birth control

FDA approves first nonprescription daily birth control in US

Opill (norgestrel) is a progestin-only daily oral contraceptive that can be purchased without prescription at drug stores, convenience stores, grocery stores and online once it becomes available to consumers.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup